These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12361104)

  • 1. Urinary excretion of ipecac alkaloids in human volunteers.
    Yamashita M; Yamashita M; Azuma J
    Vet Hum Toxicol; 2002 Oct; 44(5):257-9. PubMed ID: 12361104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.
    Asano T; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Kuroiwa Y; Fujii Y; Yamashita M; Kuramochi T; Tomisawa H; Tateishi M
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):17-27. PubMed ID: 11996323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats.
    Asano T; Watanabe J; Sadakane C; Ishihara K; Hirakura K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Fujii Y; Yamashita M
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):29-35. PubMed ID: 11996324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose pharmacokinetics of syrup of ipecac.
    Scharman EJ; Hutzler JM; Rosencrance JG; Tracy TS
    Ther Drug Monit; 2000 Oct; 22(5):566-73. PubMed ID: 11034262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipecac toxicity in "Munchausen syndrome by proxy".
    Bader AA; Kerzner B
    Ther Drug Monit; 1999 Apr; 21(2):259-60. PubMed ID: 10217350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of ipecac alkaloids in emergency patients.
    Moran DM; Crouch DJ; Finkle BS
    Ann Emerg Med; 1984 Dec; 13(12):1100-2. PubMed ID: 6150666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic assay with fluorescence detection for the determination of cephaeline and emetine in human plasma and urine.
    Asano T; Sadakane C; Ishihara K; Yanagisawa T; Kimura M; Kamei H
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):197-206. PubMed ID: 11417863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological aspects of ipecac syrup (TJN-119)-induced emesis in ferrets.
    Endo T; Nemoto M; Ogawa T; Tamakai H; Hamaue N; Hirafuji M; Takeda Y; Hasegawa M; Fugii Y; Minami M
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):187-200. PubMed ID: 11913711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology of ipecac: a review.
    Manno BR; Manno JE
    Clin Toxicol; 1977; 10(2):221-42. PubMed ID: 15766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?
    Silber TJ
    J Adolesc Health; 2005 Sep; 37(3):256-60. PubMed ID: 16109351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of 15-mL versus 30-mL doses of syrup of ipecac in children.
    Krenzelok EP; Dean BS
    Clin Pharm; 1987 Sep; 6(9):715-7. PubMed ID: 2890461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid emesis from high-dose ipecac syrup in adults and children intoxicated with antiemetics or other drugs.
    Manoguerra AS; Krenzelok EP
    Am J Hosp Pharm; 1978 Nov; 35(11):1360-2. PubMed ID: 30280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies for the emetic mechanisms of ipecac syrup (TJN-119) and its active components in ferrets: involvement of 5-hydroxytryptamine receptors.
    Hasegawa M; Sasaki T; Sadakane K; Tabuchi M; Takeda Y; Kimura M; Fujii Y
    Jpn J Pharmacol; 2002 Jun; 89(2):113-9. PubMed ID: 12120752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonemetic effects of ipecac syrup.
    Czajka PA; Russell SL
    Pediatrics; 1985 Jun; 75(6):1101-4. PubMed ID: 2860632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position paper update: ipecac syrup for gastrointestinal decontamination.
    Höjer J; Troutman WG; Hoppu K; Erdman A; Benson BE; Mégarbane B; Thanacoody R; Bedry R; Caravati EM; ;
    Clin Toxicol (Phila); 2013 Mar; 51(3):134-9. PubMed ID: 23406298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of emetic and United State pharmacopoeia ipecac syrup in prevention of drug absorption.
    Teshima D; Suzuki A; Otsubo K; Higuchi S; Aoyama T; Shimozono Y; Saita M; Noda K
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2242-5. PubMed ID: 1980639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medically unexplained myopathy due to ipecac abuse.
    Rashid N
    Psychosomatics; 2006; 47(2):167-9. PubMed ID: 16508031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betamethasone does not prevent nausea and vomiting induced by ipecacuanha.
    Axelsson P; Thörn SE; Wattwil M
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1283-6. PubMed ID: 15504189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
    Sedlacek HS; Ramsey DS; Boucher JF; Eagleson JS; Conder GA; Clemence RG
    J Vet Pharmacol Ther; 2008 Dec; 31(6):533-7. PubMed ID: 19000276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ipecac during the first hour after drug ingestion in human volunteers.
    Saincher A; Sitar DS; Tenenbein M
    J Toxicol Clin Toxicol; 1997; 35(6):609-15. PubMed ID: 9365428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.